My First-Hand Check on Medical Opportunities As I End Up in Hospital. Ref. Feedback, Avacter & Advanced Oncatherapy

Hello Share Folk. I’m going to the hospital today to see about my prostate gland. I started the routine tests a few years ago and have been under the eye of a brilliant consultant ever since. There’s a lot of debate of whether we should have these tests done, as it causes a lot of anxiety and their reliability is not always that great. On the whole I would suggest you do have them done, if you’re of a certain age.  But what do I know?

Feedback (#FDBK) says it no longer sees any point in getting FDA approval fr TexRad

Zak Mir's Bull Call Of The Day No.1:Feedback: 5p In View After Latest Gap Higher

In some ways it feels as though the latest call on Feedback is somewhat late in the day, particularly in the wake of the initial spike for the shares to start this week.

Don’t You Hate the Small Profit-Takers? ref: Feedback.

Hello Share Bunnies. There was some interesting share movements after all the good news came out for Feedback (FDBK), the minnow capitalised at a mere £5 million. 

Feedback and the Big Spanish Connection.

Hello Share Thrashers. It’s not my custom to return to promising shares I’ve brought to your attention in the recent past. I normally wait at least six months or so - with only a few exceptions.

Zak Mir's Bull Call Of The Day No.1: Feedback: 3.5p Breakout Destination

The present position for shares at Feedback (FDBK) looks to be well backed fundamentally – if you are a fan of rocket science. But as well as this we can bring in the art of technical analysis to attempt to divine where the share price may be heading near term.

The Chinese Appetite for British Medical Science Will Benefit Feedback Fans.

Feedback (FDBK) is a company going places. And it’s just gone to another one. This is a compact firm, mostly owned by family and friends, with only a small proportion of ordinary share-shifters like us.

Feedback (#FDBK) - Is "delighted with positive results" from TexRAD CT texture analysis study

Zak Mir's Great Request Show: Bowleven, Feedback, Union Jack Oil

If you want me to analyse a stock for you just drop me a line at sqmir@hotmail.com - Today I look at Bowleven (BLVN), Feedback (FDBK), Union Jack Oil (UJO)

Feedback Shares Soften, but is that a Buying Opportunity?

Hello Share Sappers. I beg your indulgence to return to Feedback (FDBK), the company which uses whizzo computers to help diagnose and monitor many types of cancer. As reported previously, this could be a topping investment. Though, as per usual, we should always add a cautionary note about medical pioneers.

I Love Feedback - It Might Make Me A Bit Better Off.

Hello Share Swingers.  It seems ages ago that I first tipped Feedback (FDBK) the life science company. It was during all the excitement about another medical punt, Advanced Oncotherapy (AVO). I think I said something optimistic along the lines that Feedback could be another Advanced, which is a multi-bagger..

IS this Beauty the next Advanced Oncotherapy? – That’s What I Heard at the Big UK Investor Show.

Hello Share Pickers. I told you I usually pick up some decent tips from the UK Investor Show which we were all treated to on Saturday. I’ve now had time to research a few of these diamonds and the first one I’ve bought is Feedback (FDBK).